Quantitative Systematic Strategies’s Vertex Pharmaceuticals VRTX Stock Holding History

Quantitative Systematic Strategies’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,762	Closed	-$355K	–	364
2021 Q2	$355K	Sell	1,762 -3,690	-68%	-$772K	0.12%	300
2021 Q1	$1.17M	Buy	5,452 +1,085	+25%	+$238K	0.18%	185
2020 Q4	$1.03M	Buy	+4,367	New	+$1M	0.15%	233
2019 Q1	–	Sell	-1,587	Closed	-$263K	–	652
2018 Q4	$263K	Buy	+1,587	New	+$275K	0.06%	453
2018 Q3	–	Sell	-1,548	Closed	-$263K	–	804
2018 Q2	$263K	Buy	+1,548	New	+$240K	0.05%	499
2017 Q4	–	Sell	-2,480	Closed	-$377K	–	665
2017 Q3	$377K	Buy	+2,480	New	+$373K	0.1%	293
2017 Q1	–	Sell	-13,428	Closed	-$1M	–	440
2016 Q4	$1M	Buy	+13,428	New	+$1.09M	0.41%	115
2016 Q3	–	Sell	-7,059	Closed	-$600K	–	502
2016 Q2	$600K	Buy	+7,059	New	+$610K	0.28%	172
2016 Q1	–	Sell	-2,418	Closed	-$306K	–	777
2015 Q4	$306K	Buy	2,418 +390	+19%	+$47.1K	0.08%	465
2015 Q3	$211K	Sell	2,028 -13,991	-87%	-$1.8M	0.1%	330
2015 Q2	$1.96M	Buy	+16,019	New	+$2.02M	0.44%	53
2015 Q1	–	Sell	-11,323	Closed	-$1.35M	–	495
2014 Q4	$1.35M	Buy	+11,323	New	+$1.28M	0.54%	57

Other funds holding VRTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Quantitative Systematic Strategies's VRTX Position: Q3 2021 in Review

Quantitative Systematic Strategies sold out of Vertex Pharmaceuticals (VRTX) in Q3 2021, closing a stake of 1,762 shares — an estimated $355K sold.

Quantitative Systematic Strategies first reported a position in VRTX in Q4 2014 and held it in 12 quarters. The position peaked at $1.96M in Q2 2015. 933 funds tracked by Wall St. Rank hold VRTX as of Q3 2021.

Quantitative Systematic Strategies reported no remaining Vertex Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
Quantitative Systematic Strategies sold 1,762 Vertex Pharmaceuticals shares in Q3 2021, an estimated $355K.
Quantitative Systematic Strategies first reported a position in Vertex Pharmaceuticals in Q4 2014 and held it in 12 quarters.
Quantitative Systematic Strategies's Vertex Pharmaceuticals position peaked at $1.96M in Q2 2015.
933 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2021.

Based on Quantitative Systematic Strategies's 13F filing for Q3 2021, filed 16 Nov 2021.